The chart below shows how CTS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CTS sees a +4.18% change in stock price 10 days leading up to the earnings, and a +4.88% change 10 days following the report. On the earnings day itself, the stock moves by -1.44%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Q4 Sales Increase: Sales for Q4 2024 reached $127 million, representing a 2% increase from Q4 2023.
End Market Sales Surge: Diversified end market sales increased by 28% in Q4 2024, highlighting strong performance in medical, aerospace, and defense sectors.
Diversified Market Sales Growth: Diversified end market sales accounted for 56% of total revenue in Q4 2024, indicating a successful shift towards these markets.
Gross Margin Improvement: Adjusted gross margin for the full year 2024 improved by 243 basis points compared to 2023, reflecting enhanced earnings quality.
Future Revenue Contributions: The company expects further revenue contributions from the SyQwest acquisition in 2025, supporting future growth initiatives.
Negative
Earnings Per Share Miss: CTS Corporation reported an EPS of $0.4471, missing expectations of $0.59 by 24.5%.
Sales Decline Overview: Total sales for the full year 2024 were $516 million, reflecting a decline of 6% compared to 2023.
Transportation Sales Decline: Transportation sales decreased by 18% in the fourth quarter compared to the same period last year, indicating significant weakness in this segment.
Book-to-Bill Ratio Stagnation: The book-to-bill ratio for the fourth quarter remained stagnant at 0.96, showing no improvement from the previous year and suggesting potential future revenue challenges.
Limited Organic Growth: Excluding the SyQwest acquisition, diversified end market sales only increased by 8% in the fourth quarter, indicating limited organic growth.
CTS Corporation (NYSE:CTS) Q4 2024 Earnings Call Transcript
CTS.N
0.79%